# Development of Novel Therapies for NIDDM

> **NCT01905722** · NA · COMPLETED · sponsor: **Duke University** · enrollment: 64 (actual)

## Conditions studied

- Metabolism

## Interventions

- **OTHER:** 3 Tesla
- **OTHER:** 7 Tesla

## Key facts

- **NCT ID:** NCT01905722
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-10
- **Primary completion:** 2017-05-17
- **Final completion:** 2017-05-17
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2019-05-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01905722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01905722, "Development of Novel Therapies for NIDDM". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01905722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*